SARS-CoV-2 seroassay optimization and performance in a population with high background reactivity in Mali
Issaka Sagara, John Woodford, Alassane Dicko, Amatigue Zeguime, M’Bouye Doucoure, Jennifer Kwan, Irfan Zaidi, Justin Doritchamou, Maryonne Snow-Smith, Nada Alani, Jonathan Renn, Ivan Kosik, Jaroslav Holly, Jonathan Yewdell, Dominic Esposito, Kaitlyn Sadtler, Patrick Duffy
doi: https://doi.org/10.1101/2021.03.08.21252784
Issaka Sagara
1MRTC/USTTB: oversight, planning, data review
John Woodford
2LMIV/NIAID/NIH: planning, data review, drafting
Alassane Dicko
1MRTC/USTTB: oversight, planning, data review
Amatigue Zeguime
3MRTC/USTTB: Mali lab activities
M’Bouye Doucoure
3MRTC/USTTB: Mali lab activities
Jennifer Kwan
4LCIM/NIAID/NIH: planning, data review
Irfan Zaidi
5LMIV/NIAID/NIH: planning, LMIV lab activities, data review
Justin Doritchamou
6LMIV/NIAID/NIH: LMIV lab activities, data review
Maryonne Snow-Smith
7LMIV/NIAID/NIH: LMIV lab activities
Nada Alani
7LMIV/NIAID/NIH: LMIV lab activities
Jonathan Renn
8LMIV/NIAID/NIH: NCP antigen production
Ivan Kosik
9LVD/NIAID/NIH: pseudovirus neutralization assay
Jaroslav Holly
10LVD/NIAID/NIH: BHK21-ACE2 expressing cell line production
Jonathan Yewdell
11LVD/NIAID/NIH: oversight pseudovirus neutralization assay
Dominic Esposito
12FNLCR/NIH: assay antigen production
Kaitlyn Sadtler
13NIBIB/NIH: advice, data review
Patrick Duffy
14LMIV/NIAID/NIH: funding, oversight, planning, data review
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted March 12, 2021.
SARS-CoV-2 seroassay optimization and performance in a population with high background reactivity in Mali
Issaka Sagara, John Woodford, Alassane Dicko, Amatigue Zeguime, M’Bouye Doucoure, Jennifer Kwan, Irfan Zaidi, Justin Doritchamou, Maryonne Snow-Smith, Nada Alani, Jonathan Renn, Ivan Kosik, Jaroslav Holly, Jonathan Yewdell, Dominic Esposito, Kaitlyn Sadtler, Patrick Duffy
medRxiv 2021.03.08.21252784; doi: https://doi.org/10.1101/2021.03.08.21252784
SARS-CoV-2 seroassay optimization and performance in a population with high background reactivity in Mali
Issaka Sagara, John Woodford, Alassane Dicko, Amatigue Zeguime, M’Bouye Doucoure, Jennifer Kwan, Irfan Zaidi, Justin Doritchamou, Maryonne Snow-Smith, Nada Alani, Jonathan Renn, Ivan Kosik, Jaroslav Holly, Jonathan Yewdell, Dominic Esposito, Kaitlyn Sadtler, Patrick Duffy
medRxiv 2021.03.08.21252784; doi: https://doi.org/10.1101/2021.03.08.21252784
Subject Area
Subject Areas
- Addiction Medicine (339)
- Allergy and Immunology (665)
- Anesthesia (179)
- Cardiovascular Medicine (2621)
- Dermatology (220)
- Emergency Medicine (396)
- Epidemiology (12163)
- Forensic Medicine (10)
- Gastroenterology (754)
- Genetic and Genomic Medicine (4054)
- Geriatric Medicine (383)
- Health Economics (674)
- Health Informatics (2617)
- Health Policy (996)
- Hematology (359)
- HIV/AIDS (840)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (429)
- Neurology (3824)
- Nursing (208)
- Nutrition (569)
- Oncology (2004)
- Ophthalmology (580)
- Orthopedics (238)
- Otolaryngology (303)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (470)
- Pediatrics (1107)
- Primary Care Research (445)
- Public and Global Health (6495)
- Radiology and Imaging (1385)
- Respiratory Medicine (868)
- Rheumatology (399)
- Sports Medicine (338)
- Surgery (440)
- Toxicology (52)
- Transplantation (185)
- Urology (165)